Evidence map›Paper›PMID 27795941›Full record

ArticleCurrent pharmacology reports2016

A Molecular Aspect in the Regulation of Drug Metabolism: Does PXR-Induced Enzyme Expression Always Lead to Functional Changes in Drug Metabolism?

Yuan Wei, Chenxiao Tang, Vinayak Sant, Song Li, Samuel M Poloyac, Wen Xie

Open access · bronzeAbstract read
In one paragraph

Article in Current pharmacology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Design and Optimization of 1Journal of medicinal chemistry · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. PXR as a mediator of herb-drug interaction.Journal of food and drug analysis · 2018
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yuan WeiDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, 306 Salk Pavilion, 335 Sutherland Drive, Pittsburgh, PA 15261, USA.
Chenxiao TangDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, 306 Salk Pavilion, 335 Sutherland Drive, Pittsburgh, PA 15261, USA.
Vinayak SantDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, 306 Salk Pavilion, 335 Sutherland Drive, Pittsburgh, PA 15261, USA.
Song LiDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, 306 Salk Pavilion, 335 Sutherland Drive, Pittsburgh, PA 15261, USA.
Samuel M PoloyacDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, 306 Salk Pavilion, 335 Sutherland Drive, Pittsburgh, PA 15261, USA.
Wen XieDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, 306 Salk Pavilion, 335 Sutherland Drive, Pittsburgh, PA 15261, USA.
University of Pittsburgh · US

Funding

The AHR-FGF221 Axis in Hepatic Steatosis and Metobolic SyndromeR01DK083952 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIE, WEN · 2010 to 2019
$3.0M
A Novel Regulation of the Phase II Enzyme Estrogen SulfotransferaseR01ES023438 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIE, WEN · 2014 to 2018
$1.7M
The Perinatal Pharmacology of the Nuclear ReceptorR01HD073070 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIE, WEN · 2013 to 2017
$1.6M
The hepatic function of cholesterol sulfotransferase 2B1b (SULT2B1b)in energy metR01DK099232 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIE, WEN · 2014 to 2017
$1.3M
NICHD NIH HHS R01 HD073070NIDDK NIH HHS R01 DK083952NIDDK NIH HHS R01 DK099232NIEHS NIH HHS R01 ES023438
6 · The paper itself

Abstract

Pregnane X receptor (PXR, NR112) is a xenobiotic receptor whose primary function is to regulate the expression of drug-metabolizing enzymes (DMEs) and drug transporters. Drug-induced PXR activation and subsequent enzyme and transporter induction has been proposed to be an important mechanism for the drug-drug interactions. In addition to activating PXR, many pharmaceutical chemicals can also function as reversible or irreversible inhibitors of DMEs, which may also impact the pharmacokinetics and pharmacodynamics (PK/PD) of drugs. Therefore, we cannot simply conclude that the PXR-induced alteration in enzyme expression always reflects functional changes. We should consider both PXR activation and DMEs inhibition to improve drug safety in the clinic.

Indexed as

Drug metabolismEnzyme inhibitionGene regulationNuclear receptor

Identifiers

PMID27795941
PMCPMC5082989
OpenAlexW2345580546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.